Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share (SCTX)

Q: What does CUSIP 811033109 represent in this 13F holders report?

CUSIP 811033109 is the security identifier for SCTX - Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held SCTX - Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share in Q3 2026?

23 institutional investors reported SCTX - Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share for Q3 2026. Use the holders table for investor-level position and value details.

CUSIP: 811033109

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.001 par value per share
Total 13F shares: 3,005,312
Total 13F value: $55,081,573
Share change: +3,002,912
SEC-reported price per share: $18.40
Number of holders: 23
Value change: +$55,037,401
Number of buys: 22
Shares outstanding: 18,772,688

Security key

811033109

Report period

Q3 2026

Institutions

Top holders

SCTX full security history Ownership snapshot Full 13F holder table Scribe Therapeutics, Inc. SEC filings Scribe Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 811033109

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of SCTX - Scribe Therapeutics, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Avoro Capital Advisors LLC

Disclosed value leader

AH Bio Fund II, L.P.

Comparable rows

4/15

Latest evidence

27 Jul 2026

3/4/5 13D/G Lead comparable stake: 16% 11 rows are not safely comparable across share classes. 13D/G row: Avoro Capital Advisors LLC Showing 1-6 of 15 holder rows.

Quick read

Avoro Capital Advisors LLC leads the comparable SEC ownership view at 16%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Avoro Capital Advisors LLC's linked filing trail.

Comparable ownership Top 4

Avoro Capital Advisors LLC 16%

RA CAPITAL MANAGEMENT, L.P. 9.6%

ELI LILLY & Co 7.3%

ORBIMED ADVISORS LLC 7.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Avoro Capital Advisors LLC	3/4/5 13D/G Director, Other*, 10%+ Owner · Aghazadeh Behzad 3/4/5 13D/G	16% Reported 13D/G · 24 Jul 2026	— 3,103,613 shares mixed-class rows	—	24 Jul 2026
RA CAPITAL MANAGEMENT, L.P.	13D/G 13D/G	9.6% Reported 13D/G · 27 Jul 2026	— 1,802,178 shares	$0	27 Jul 2026
ELI LILLY & Co	3/4/5 13D/G 10%+ Owner 3/4/5 13D/G	7.3% Reported 13D/G · 23 Jul 2026	— 1,054,828 shares	—	23 Jul 2026
ORBIMED ADVISORS LLC	3/4/5 13D/G Director 3/4/5 13D/G	7.2% Reported 13D/G · 27 Jul 2026	$24,764,427 1,348,825 shares	—	27 Jul 2026
AH Bio Fund II, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$56,598,831 3,082,725 shares	—	27 Jul 2026
AH Bio Fund III, L.P.	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$56,598,831 3,082,725 shares	—	27 Jul 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

3,005,312

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders

Q3 2026 holders

Holder diff

Investor	Q2 2026 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend